---
name: VIRSCIO
slug: virscio
site: cro
website_domain: virscio.com
summary: Virscio runs African green monkey studies for efficacy, safety, PK/PD and delivery alongside digital histopathology and molecular biology. Its GLP-operated, AAALAC-accredited primate program supports IND-enabling work in CNS, ophthalmology, and gene therapy. Headquartered in New Haven, United States.
tagline: Solving significant human health challenges through preclinical precision and innovation
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: US
tier2_domain_verified: false
updated_at: 2026-10-26T07:04:06.943Z
services_count: 7
modalities_count: 2
indications_count: 4
locations_count: 1
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# VIRSCIO

Solving significant human health challenges through preclinical precision and innovation

Listed on cro.directory.

## Summary

Virscio runs African green monkey studies for efficacy, safety, PK/PD and delivery alongside digital histopathology and molecular biology. Its GLP-operated, AAALAC-accredited primate program supports IND-enabling work in CNS, ophthalmology, and gene therapy. Headquartered in New Haven, United States.

## At a glance

- HQ country: US

## Services

- Preclinical In Vivo Studies
- In Vivo Efficacy Models
- In Vivo PK / PD Studies
- Specialized & Large-Animal Models
- Pathology & Histology Services
- Translational Research
- Regulatory Affairs

## Modalities

- Gene Therapy
- Cell Therapy

## Indications

- Neurology
- Ophthalmology
- Cardiovascular
- Metabolic

## Locations

- New Haven, New Haven, CT, United States

## Long description

## Overview

Virscio provides translational preclinical research supported by advanced imaging, histopathology, molecular analysis, and African green monkey (NHP) models.

## Services

- **NHP research services:** in vivo primate efficacy and safety, pharmacokinetics, pharmacodynamics, and delivery studies.
- **Histopathology services:** digital histopathology integrated with in vivo research.
- **Molecular biology services:** molecular analysis supporting translational models.
- **Strategy and execution:** preclinical strategy, protocol design, in-life study execution, sample processing, data analysis, study reporting, and defining the regulatory pathway, from IND-enabling safety studies onward.

## Compliance

Virscio states that its animal program consistently meets AAALAC and OLAW standards, aligned with USDA and European animal welfare guidance. The company operates under FDA good laboratory practice (GLP) and supports studies intended for regulatory submission under OECD GLP.

## Therapeutic focus

Capabilities are described across central nervous system, ophthalmology, cardiometabolic, gene and cell therapies, protein and RNA therapies, and aging biology.

## Related companies

- [JOINN Biomere](/companies/biomere) (Preclinical In Vivo Studies, In Vivo Efficacy Models) — [Compare](/compare/biomere/virscio)
- [Cyagen Biosciences](/companies/apac-cyagen) (Preclinical In Vivo Studies, In Vivo Efficacy Models) — [Compare](/compare/apac-cyagen/virscio)
- [Cyagen Biosciences](/companies/cyagen) (Preclinical In Vivo Studies, In Vivo Efficacy Models) — [Compare](/compare/cyagen/virscio)
- [NorthernBio](/companies/northernbiolab) (Preclinical In Vivo Studies, In Vivo Efficacy Models) — [Compare](/compare/northernbiolab/virscio)
- [Inotiv](/companies/inotivco) (Preclinical In Vivo Studies, In Vivo Efficacy Models) — [Compare](/compare/inotivco/virscio)
- [StemExpress](/companies/stemexpress) (Translational Research, Gene Therapy) — [Compare](/compare/stemexpress/virscio)
- [Crown Bioscience](/companies/crownbio) (Preclinical In Vivo Studies, In Vivo Efficacy Models) — [Compare](/compare/crownbio/virscio)
- [Creative Bioarray](/companies/creative-bioarray) (Preclinical In Vivo Studies, In Vivo PK / PD Studies) — [Compare](/compare/creative-bioarray/virscio)

_Profile last updated: 2026-10-26T07:04:06.943Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.